1. Home
  2. FBGL vs CLDI Comparison

FBGL vs CLDI Comparison

Compare FBGL & CLDI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

FBGL

FBS Global Limited Ordinary Shares

HOLD

Current Price

$0.83

Market Cap

10.5M

ML Signal

HOLD

Logo Calidi Biotherapeutics Inc.

CLDI

Calidi Biotherapeutics Inc.

HOLD

Current Price

$1.39

Market Cap

9.9M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
FBGL
CLDI
Founded
1996
2014
Country
Singapore
United States
Employees
N/A
N/A
Industry
Miscellaneous manufacturing industries
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
10.5M
9.9M
IPO Year
2025
N/A

Fundamental Metrics

Financial Performance
Metric
FBGL
CLDI
Price
$0.83
$1.39
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
945.2K
81.8K
Earning Date
05-15-2026
11-13-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$10,491,303.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.41
$1.10
52 Week High
$5.45
$23.16

Technical Indicators

Market Signals
Indicator
FBGL
CLDI
Relative Strength Index (RSI) 66.87 41.18
Support Level $0.76 $1.41
Resistance Level $0.90 $1.52
Average True Range (ATR) 0.10 0.09
MACD 0.01 -0.00
Stochastic Oscillator 76.68 19.57

Price Performance

Historical Comparison
FBGL
CLDI

About FBGL FBS Global Limited Ordinary Shares

FBS Global Ltd is a green building contractor and an established interior fit-out specialist in institutional, residential, commercial, and industrial building projects. As a green contractor focused on environmentally sound practices, the company aims to bid tenders for green building projects, use green construction methods and green materials for construction projects, including design, supply and installation of ceilings, partitions, timber deck, carpet, acoustic wall paneling, built-in furniture as well as mechanical and electrical services of a building. The company's revenue is derived mainly from the construction contracts and Sales of construction materials.

About CLDI Calidi Biotherapeutics Inc.

Calidi Biotherapeutics Inc is a clinical-stage immuno-oncology company with technology designed to arm the immune system to fight cancer. The Company's stem cell-based platforms utilize potent allogeneic stem cells capable of carrying payloads of oncolytic viruses for use in a many oncology indications, including high-grade gliomas and solid tumors. Its products include CLD-101 for Recurrent HGG; CLD-201 for Solid Tumors, and CLD-400 for certain lung cancer and Metastatic Solid Tumors. In addition to its pipeline products, the Company's is also engaged in discovery research of CLD-301 (AAA) for tumor Indications.

Share on Social Networks: